Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Erosion-Protective Capacity of the Salivary Pellicle of Female and Male Subjects Is Not Different.

Wiegand A, Rosemann A, Hoch M, Barke S, Dakna M, Kanzow P.

Caries Res. 2019 Jun 4:1-7. doi: 10.1159/000500046. [Epub ahead of print]

PMID:
31163440
2.

Drug Survival und Gründe für einen Therapieabbruch bei Pustulosis palmoplantaris: Eine retrospektive multizentrische Studie.

Kromer C, Wilsmann-Theis D, Gerdes S, Philipp S, Schaarschmidt ML, Schmieder A, Dakna M, Arnold T, Peitsch WK, Mössner R.

J Dtsch Dermatol Ges. 2019 May;17(5):503-517. doi: 10.1111/ddg.13834_g.

PMID:
31115984
3.

Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study.

Kromer C, Wilsmann-Theis D, Gerdes S, Philipp S, Schaarschmidt ML, Schmieder A, Dakna M, Arnold T, Peitsch WK, Mössner R.

J Dtsch Dermatol Ges. 2019 May;17(5):503-516. doi: 10.1111/ddg.13834. Epub 2019 Apr 17.

4.

Proteome Profiling by Label-Free Mass Spectrometry Reveals Differentiated Response of Campylobacter jejuni 81-176 to Sublethal Concentrations of Bile Acids.

Masanta WO, Zautner AE, Lugert R, Bohne W, Gross U, Leha A, Dakna M, Lenz C.

Proteomics Clin Appl. 2019 May;13(3):e1800083. doi: 10.1002/prca.201800083. Epub 2018 Oct 11.

5.

Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression.

Pejchinovski M, Siwy J, Metzger J, Dakna M, Mischak H, Klein J, Jankowski V, Bae KT, Chapman AB, Kistler AD.

Nephrol Dial Transplant. 2017 Mar 1;32(3):487-497. doi: 10.1093/ndt/gfw243.

PMID:
27382111
6.

Development of a MALDI MS-based platform for early detection of acute kidney injury.

Carrick E, Vanmassenhove J, Glorieux G, Metzger J, Dakna M, Pejchinovski M, Jankowski V, Mansoorian B, Husi H, Mullen W, Mischak H, Vanholder R, Van Biesen W.

Proteomics Clin Appl. 2016 Jul;10(7):732-42. doi: 10.1002/prca.201500117. Epub 2016 May 17.

7.

Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.

Frantzi M, van Kessel KE, Zwarthoff EC, Marquez M, Rava M, Malats N, Merseburger AS, Katafigiotis I, Stravodimos K, Mullen W, Zoidakis J, Makridakis M, Pejchinovski M, Critselis E, Lichtinghagen R, Brand K, Dakna M, Roubelakis MG, Theodorescu D, Vlahou A, Mischak H, Anagnou NP.

Clin Cancer Res. 2016 Aug 15;22(16):4077-86. doi: 10.1158/1078-0432.CCR-15-2715. Epub 2016 Mar 29.

8.

Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic Pancreatitis.

Schönemeier B, Metzger J, Klein J, Husi H, Bremer B, Armbrecht N, Dakna M, Schanstra JP, Rosendahl J, Wiegand J, Jäger M, Mullen W, Breuil B, Plentz RR, Lichtinghagen R, Brand K, Kühnel F, Mischak H, Manns MP, Lankisch TO.

Pancreas. 2016 Aug;45(7):1018-26. doi: 10.1097/MPA.0000000000000573.

PMID:
26784907
9.

Identification of ageing-associated naturally occurring peptides in human urine.

Nkuipou-Kenfack E, Bhat A, Klein J, Jankowski V, Mullen W, Vlahou A, Dakna M, Koeck T, Schanstra JP, Zürbig P, Rudolph KL, Schumacher B, Pich A, Mischak H.

Oncotarget. 2015 Oct 27;6(33):34106-17. doi: 10.18632/oncotarget.5896.

10.

Two-group comparisons of zero-inflated intensity values: the choice of test statistic matters.

Gleiss A, Dakna M, Mischak H, Heinze G.

Bioinformatics. 2015 Jul 15;31(14):2310-7. doi: 10.1093/bioinformatics/btv154. Epub 2015 Mar 18.

PMID:
25788623
11.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R.

J Am Soc Nephrol. 2015 Aug;26(8):1999-2010. doi: 10.1681/ASN.2014050423. Epub 2015 Jan 14.

12.

Integrating proteomics profiling data sets: a network perspective.

Bhat A, Dakna M, Mischak H.

Methods Mol Biol. 2015;1243:237-53. doi: 10.1007/978-1-4939-1872-0_14. Review.

PMID:
25384750
13.

Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.

Chinello C, Cazzaniga M, De Sio G, Smith AJ, Gianazza E, Grasso A, Rocco F, Signorini S, Grasso M, Bosari S, Zoppis I, Dakna M, van der Burgt YE, Mauri G, Magni F.

PLoS One. 2014 Sep 9;9(9):e106684. doi: 10.1371/journal.pone.0106684. eCollection 2014.

14.

Identification of urinary peptide biomarkers associated with rheumatoid arthritis.

Stalmach A, Johnsson H, McInnes IB, Husi H, Klein J, Dakna M, Mullen W, Mischak H, Porter D.

PLoS One. 2014 Aug 21;9(8):e104625. doi: 10.1371/journal.pone.0104625. eCollection 2014.

15.

Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.

Nkuipou-Kenfack E, Duranton F, Gayrard N, Argilés À, Lundin U, Weinberger KM, Dakna M, Delles C, Mullen W, Husi H, Klein J, Koeck T, Zürbig P, Mischak H.

PLoS One. 2014 May 9;9(5):e96955. doi: 10.1371/journal.pone.0096955. eCollection 2014.

16.

Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.

Frantzi M, Metzger J, Banks RE, Husi H, Klein J, Dakna M, Mullen W, Cartledge JJ, Schanstra JP, Brand K, Kuczyk MA, Mischak H, Vlahou A, Theodorescu D, Merseburger AS.

J Proteomics. 2014 Feb 26;98:44-58. doi: 10.1016/j.jprot.2013.12.010. Epub 2013 Dec 25.

PMID:
24374379
17.

Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV).

Klein J, Lacroix C, Caubet C, Siwy J, Zürbig P, Dakna M, Muller F, Breuil B, Stalmach A, Mullen W, Mischak H, Bandin F, Monsarrat B, Bascands JL, Decramer S, Schanstra JP.

Sci Transl Med. 2013 Aug 14;5(198):198ra106. doi: 10.1126/scitranslmed.3005807.

18.

CKD273, a new proteomics classifier assessing CKD and its prognosis.

Argilés Á, Siwy J, Duranton F, Gayrard N, Dakna M, Lundin U, Osaba L, Delles C, Mourad G, Weinberger KM, Mischak H.

PLoS One. 2013 May 14;8(5):e62837. doi: 10.1371/journal.pone.0062837. Print 2013.

19.

A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases.

Molin L, Seraglia R, Lapolla A, Ragazzi E, Gonzalez J, Vlahou A, Schanstra JP, Albalat A, Dakna M, Siwy J, Jankowski J, Bitsika V, Mischak H, Zürbig P, Traldi P.

J Proteomics. 2012 Oct 22;75(18):5888-97. doi: 10.1016/j.jprot.2012.07.024. Epub 2012 Jul 26.

PMID:
22842158
20.

Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.

Metzger J, Negm AA, Plentz RR, Weismüller TJ, Wedemeyer J, Karlsen TH, Dakna M, Mullen W, Mischak H, Manns MP, Lankisch TO.

Gut. 2013 Jan;62(1):122-30. doi: 10.1136/gutjnl-2012-302047. Epub 2012 May 12.

PMID:
22580416
21.

Addressing the challenge of defining valid proteomic biomarkers and classifiers.

Dakna M, Harris K, Kalousis A, Carpentier S, Kolch W, Schanstra JP, Haubitz M, Vlahou A, Mischak H, Girolami M.

BMC Bioinformatics. 2010 Dec 10;11:594. doi: 10.1186/1471-2105-11-594.

22.

Recommendations for biomarker identification and qualification in clinical proteomics.

Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman RR, Ioannidis JP, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sánchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovski G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra TD, Weissinger E, Yamamoto T, Vlahou A.

Sci Transl Med. 2010 Aug 25;2(46):46ps42. doi: 10.1126/scitranslmed.3001249.

PMID:
20739680
23.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8.

24.

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, Dakna M, Coon JJ, Mischak H.

Mol Cell Proteomics. 2009 Oct;8(10):2296-307. doi: 10.1074/mcp.M800529-MCP200. Epub 2009 Jun 28.

25.

Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease.

Kistler AD, Mischak H, Poster D, Dakna M, Wüthrich RP, Serra AL.

Kidney Int. 2009 Jul;76(1):89-96. doi: 10.1038/ki.2009.93. Epub 2009 Apr 1.

26.

The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease.

Zürbig P, Decramer S, Dakna M, Jantos J, Good DM, Coon JJ, Bandin F, Mischak H, Bascands JL, Schanstra JP.

Proteomics. 2009 Apr;9(8):2108-17. doi: 10.1002/pmic.200800560.

27.

Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment.

Dakna M, He Z, Yu WC, Mischak H, Kolch W.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 May 1;877(13):1250-8. doi: 10.1016/j.jchromb.2008.10.048. Epub 2008 Nov 6. Review.

PMID:
19010091
28.

CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.

Coon JJ, Zürbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, Frommberger M, Golovko I, Good DM, Herget-Rosenthal S, Jankowski J, Julian BA, Kellmann M, Kolch W, Massy Z, Novak J, Rossing K, Schanstra JP, Schiffer E, Theodorescu D, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Proteomics Clin Appl. 2008 Jul 10;2(7-8):964.

29.

Urinary proteomics in diabetes and CKD.

Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P; PREDICTIONS Network.

J Am Soc Nephrol. 2008 Jul;19(7):1283-90. doi: 10.1681/ASN.2007091025. Epub 2008 Apr 30.

Supplemental Content

Support Center